Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis

PHASE3CompletedINTERVENTIONAL
Enrollment

877

Participants

Timeline

Start Date

January 7, 2003

Primary Completion Date

June 18, 2007

Study Completion Date

June 18, 2007

Conditions
Kidney FailureHemodialysis Fistula Thrombosis
Interventions
DRUG

Clopidogrel

DRUG

Placebo

Trial Locations (9)

27157

Wake Forest University, Winston-Salem

27710

Duke University Medical Center, Durham

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University, Nashville

52242

University of Iowa, Iowa City

63110

Washington University, St Louis

75390

University of Texas Southwestern, Dallas

04102

Maine Medical Center, Portland

02118

Boston University Medical Center, Boston

Sponsors
All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

collaborator

Boston University

OTHER

collaborator

Duke University

OTHER

collaborator

University of Iowa

OTHER

collaborator

MaineHealth

OTHER

collaborator

University of Texas Southwestern Medical Center

OTHER

collaborator

University of Alabama at Birmingham

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

Baystate Medical Center

OTHER

collaborator

Vanderbilt University

OTHER

collaborator

CAMC Health System

OTHER

collaborator

Emory University

OTHER

collaborator

St. Louis University

OTHER

collaborator

Tyler Nephrology Associates

UNKNOWN

collaborator

Vascular Surgery Associates LLC

OTHER

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH